Leishmania vaccine development: exploiting the host–vector–parasite interface
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Leishmania vaccine development: exploiting the host–vector–parasite interface
Authors
Keywords
-
Journal
Expert Review of Vaccines
Volume 15, Issue 1, Pages 81-90
Publisher
Informa UK Limited
Online
2015-11-23
DOI
10.1586/14760584.2016.1105135
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Innate immunity againstLeishmaniainfections
- (2015) Prajwal Gurung et al. CELLULAR MICROBIOLOGY
- New World and Old World Leishmania Infections
- (2015) Ines Kevric et al. DERMATOLOGIC CLINICS
- A sand fly salivary protein vaccine shows efficacy against vector-transmitted cutaneous leishmaniasis in nonhuman primates
- (2015) Fabiano Oliveira et al. Science Translational Medicine
- A Review: The Current In Vivo Models for the Discovery and Utility of New Anti-leishmanial Drugs Targeting Cutaneous Leishmaniasis
- (2015) Emily Rose Mears et al. PLoS Neglected Tropical Diseases
- Parasite load estimation by qPCR differentiates between asymptomatic and symptomatic infection in Indian visceral leishmaniasis
- (2014) Medhavi Sudarshan et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Immunity to visceral leishmaniasis: implications for immunotherapy
- (2014) Forough Khadem et al. Future Microbiology
- What’s behind a sand fly bite? The profound effect of sand fly saliva on host hemostasis, inflammation and immunity
- (2014) Maha Abdeladhim et al. INFECTION GENETICS AND EVOLUTION
- Characterisation of the ex vivo virulence of Leishmania infantum isolates from Phlebotomus perniciosus from an outbreak of human leishmaniosis in Madrid, Spain
- (2014) Gustavo Domínguez-Bernal et al. Parasites & Vectors
- Generation of growth arrested Leishmania amastigotes: A tool to develop live attenuated vaccine candidates against visceral leishmaniasis
- (2014) Angamuthu Selvapandiyan et al. VACCINE
- Enhanced Protective Efficacy of Nonpathogenic Recombinant Leishmania tarentolae Expressing Cysteine Proteinases Combined with a Sand Fly Salivary Antigen
- (2014) Farnaz Zahedifard et al. PLoS Neglected Tropical Diseases
- Quantitative PCR in Epidemiology for Early Detection of Visceral Leishmaniasis Cases in India
- (2014) Medhavi Sudarshan et al. PLoS Neglected Tropical Diseases
- Visceral Leishmaniasis: Advancements in Vaccine Development via Classical and Molecular Approaches
- (2014) Sumit Joshi et al. Frontiers in Immunology
- Immunotherapy and Immunochemotherapy in Visceral Leishmaniasis: Promising Treatments for this Neglected Disease
- (2014) Bruno Mendes Roatt et al. Frontiers in Immunology
- Epidemiology of visceral leishmaniasis
- (2014) Paul Ready Clinical Epidemiology
- Biomarkers for intracellular pathogens: establishing tools as vaccine and therapeutic endpoints for visceral leishmaniasis
- (2013) A.C. Vallur et al. CLINICAL MICROBIOLOGY AND INFECTION
- A New Model of Progressive Visceral Leishmaniasis in Hamsters by Natural Transmission via Bites of Vector Sand Flies
- (2013) Hamide Aslan et al. JOURNAL OF INFECTIOUS DISEASES
- Case study for a vaccine against leishmaniasis
- (2013) Jorge Alvar et al. VACCINE
- Lufaxin, a Novel Factor Xa Inhibitor From the Salivary Gland of the Sand Fly Lutzomyia longipalpis Blocks Protease-Activated Receptor 2 Activation and Inhibits Inflammation and Thrombosis In Vivo
- (2012) Nicolas Collin et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Immunity to Sand Fly Salivary Protein LJM11 Modulates Host Response to Vector-Transmitted Leishmania Conferring Ulcer-Free Protection
- (2012) Regis Gomes et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Delayed-Type Hypersensitivity to Sand Fly Saliva in Humans from a Leishmaniasis-Endemic Area of Mali Is TH1-Mediated and Persists to Midlife
- (2012) Fabiano Oliveira et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Phlebotomine sandflies and the spreading of leishmaniases and other diseases of public health concern
- (2012) M. MAROLI et al. MEDICAL AND VETERINARY ENTOMOLOGY
- Leishmaniasis Worldwide and Global Estimates of Its Incidence
- (2012) Jorge Alvar et al. PLoS One
- Micro/nanoparticle adjuvants for antileishmanial vaccines: Present and future trends
- (2012) Ali Badiee et al. VACCINE
- The Role of Leishmania Proteophosphoglycans in Sand Fly Transmission and Infection of the Mammalian Host
- (2012) Matthew E. Rogers Frontiers in Microbiology
- The Immune Response to Sand Fly Salivary Proteins and Its Influence on Leishmania Immunity
- (2012) Regis Gomes et al. Frontiers in Immunology
- Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant
- (2011) Rhea N. Coler et al. PLoS One
- Targeting TLRs Expands the Antibody Repertoire in Response to a Malaria Vaccine
- (2011) S. R. Wiley et al. Science Translational Medicine
- The development and clinical evaluation of second-generation leishmaniasis vaccines
- (2011) Malcolm S. Duthie et al. VACCINE
- Lutzomyia longipalpis Saliva or Salivary Protein LJM19 Protects against Leishmania braziliensis and the Saliva of Its Vector, Lutzomyia intermedia
- (2011) Natalia M. Tavares et al. PLoS Neglected Tropical Diseases
- A Synthetic Adjuvant to Enhance and Expand Immune Responses to Influenza Vaccines
- (2010) Rhea N. Coler et al. PLoS One
- A Defined Tuberculosis Vaccine Candidate Boosts BCG and Protects Against Multidrug-Resistant Mycobacterium tuberculosis
- (2010) S. Bertholet et al. Science Translational Medicine
- Discovery of Markers of Exposure Specific to Bites of Lutzomyia longipalpis, the Vector of Leishmania infantum chagasi in Latin America
- (2010) Clarissa Teixeira et al. PLoS Neglected Tropical Diseases
- Design, Development and Evaluation of rK28-Based Point-of-Care Tests for Improving Rapid Diagnosis of Visceral Leishmaniasis
- (2010) Sowmya Pattabhi et al. PLoS Neglected Tropical Diseases
- Leishmaniasis: Current Treatment and Prospects for New Drugs and Vaccines
- (2009) Lukasz Kedzierski et al. CURRENT MEDICINAL CHEMISTRY
- Sand Fly Salivary Proteins Induce Strong Cellular Immunity in a Natural Reservoir of Visceral Leishmaniasis with Adverse Consequences for Leishmania
- (2009) Nicolas Collin et al. PLoS Pathogens
- Vector Transmission of Leishmania Abrogates Vaccine-Induced Protective Immunity
- (2009) Nathan C. Peters et al. PLoS Pathogens
- Immunity to a salivary protein of a sand fly vector protects against the fatal outcome of visceral leishmaniasis in a hamster model
- (2008) R. Gomes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunity to Distinct Sand Fly Salivary Proteins Primes the Anti-Leishmania Immune Response towards Protection or Exacerbation of Disease
- (2008) Fabiano Oliveira et al. PLoS Neglected Tropical Diseases
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More